Progress Treating Disease

Research does not end once a medicine is approved by the U.S. Food and Drug Administration; it is built upon to improve outcomes for patients, simplify treatment regimens and monitor safety. America’s biopharmaceutical research companies are committed to a dynamic research ecosystem that delivers safe and efficacious treatments to patients. Explore how far we’ve come in fighting disease.

Progress in Fighting Rare Diseases

Biopharmaceutical industry researchers are making great progress in the fight against rare diseases as innovative science has opened new opportunities.


Read More
Progress Treating Diabetes

Progress in Treating Diabetes

Today, more than 30 million Americans are living with diabetes. Learn more about the prevalence of the illness in the United States, the importance of continued research and the progress in treating the disease.


From Pharma

Stopping the Spread of Ebola

Stopping the spread of Ebola will require close collaboration and engagement from stakeholders across the health care system, and the biopharmaceutical industry stands ready to do its part.


The Value of Cancer Treatment Today

In recent decades, tremendous progress has been made in the fight against cancer. Research has expanded our knowledge of how the disease develops and how to target medicine.